BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3754862)

  • 1. The semiquinone state of NADPH-adrenodoxin oxidoreductase in the course of anaerobic reduction with NADPH.
    Nonaka Y; Fujii S; Yamano T
    J Biochem; 1986 Mar; 99(3):803-14. PubMed ID: 3754862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Equilibrium and transient state spectrophotometric studies of the mechanism of reduction of the flavoprotein domain of P450BM-3.
    Sevrioukova I; Shaffer C; Ballou DP; Peterson JA
    Biochemistry; 1996 Jun; 35(22):7058-68. PubMed ID: 8679531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenodoxin reductase. Properties of the complexes of reduced enzyme with NADP+ and NADPH.
    Lambeth JD; Kamin H
    J Biol Chem; 1976 Jul; 251(14):4299-306. PubMed ID: 6475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences between the reactivities of two pyridine nucleotides in the rapid reduction process and the reoxidation process of adrenodoxin reductase.
    Sugiyama T; Miura R; Yamano T
    J Biochem; 1979 Jul; 86(1):213-23. PubMed ID: 39065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic, spectroscopic and thermodynamic characterization of the Mycobacterium tuberculosis adrenodoxin reductase homologue FprA.
    McLean KJ; Scrutton NS; Munro AW
    Biochem J; 2003 Jun; 372(Pt 2):317-27. PubMed ID: 12614197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the reaction mechanism of NADPH-adrenodoxin reductase with NADPH.
    Sakamoto H; Ohta M; Miura R; Sugiyama T; Yamano T; Miyake Y
    J Biochem; 1982 Dec; 92(6):1941-50. PubMed ID: 7161267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectroscopic properties of Escherichia coli UDP-N-acetylenolpyruvylglucosamine reductase.
    Axley MJ; Fairman R; Yanchunas J; Villafranca JJ; Robertson JG
    Biochemistry; 1997 Jan; 36(4):812-22. PubMed ID: 9020779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium tuberculosis FprA, a novel bacterial NADPH-ferredoxin reductase.
    Fischer F; Raimondi D; Aliverti A; Zanetti G
    Eur J Biochem; 2002 Jun; 269(12):3005-13. PubMed ID: 12071965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional interactions in cytochrome P450BM3: flavin semiquinone intermediates, role of NADP(H), and mechanism of electron transfer by the flavoprotein domain.
    Murataliev MB; Klein M; Fulco A; Feyereisen R
    Biochemistry; 1997 Jul; 36(27):8401-12. PubMed ID: 9204888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flavin analogs as mechanistic probes of adrenodoxin reductase-dependent electron transfer to the cholesterol side chain cleavage cytochrome P-450 of the adrenal cortex.
    Light DR; Walsh C
    J Biol Chem; 1980 May; 255(9):4264-77. PubMed ID: 6246117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A 31P-nuclear-magnetic-resonance study of NADPH-cytochrome-P-450 reductase and of the Azotobacter flavodoxin/ferredoxin-NADP+ reductase complex.
    Bonants PJ; Müller F; Vervoort J; Edmondson DE
    Eur J Biochem; 1990 Jul; 190(3):531-7. PubMed ID: 2115440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electron transfer in human methionine synthase reductase studied by stopped-flow spectrophotometry.
    Wolthers KR; Scrutton NS
    Biochemistry; 2004 Jan; 43(2):490-500. PubMed ID: 14717604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenodoxin reductase and adrenodoxin. Mechanisms of reduction of ferricyanide and cytochrome c.
    Lambeth JD; Kamin H
    J Biol Chem; 1977 May; 252(9):2908-17. PubMed ID: 16008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential.
    Shen AL; Kasper CB
    Biochemistry; 1996 Jul; 35(29):9451-9. PubMed ID: 8755724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of flavin adenine dinucleotide and tryptophan NADPH-adrenodoxin reductase complexed with adrenodoxin].
    Mardanian SS; Sarkisova EG
    Biofizika; 1995; 40(1):23-9. PubMed ID: 7703274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formation of the semiquinone form in the anaerobic reduction of adrenodoxin reductase by NADPH. Resonance Raman, EPR, and optical spectroscopic evidence.
    Kitagawa T; Sakamoto H; Sugiyama T; Yamano T
    J Biol Chem; 1982 Oct; 257(20):12075-80. PubMed ID: 6288706
    [No Abstract]   [Full Text] [Related]  

  • 17. Phosphorus-31 nuclear magnetic resonance and electronic spectroscopic studies of adrenodoxin reductase and its binary complex with NADP+.
    Nonaka Y; Fujii S; Yamano T
    J Biochem; 1985 May; 97(5):1263-71. PubMed ID: 2993264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified liver microsomal NADPH-cytochrome P-450 reductase. Spectral characterization of oxidation-reduction states.
    Vermilion JL; Coon MJ
    J Biol Chem; 1978 Apr; 253(8):2694-704. PubMed ID: 632295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of NADPH-adrenodoxin reductase with NADP+ as studied by pulse radiolysis.
    Kobayashi K; Miura S; Miki M; Ichikawa Y; Tagawa S
    Biochemistry; 1995 Oct; 34(40):12932-6. PubMed ID: 7548051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reduction of putidaredoxin reductase by reduced pyridine nucleotides.
    Roome PW; Peterson JA
    Arch Biochem Biophys; 1988 Oct; 266(1):32-40. PubMed ID: 3178230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.